Oxford Sciences Innovation

Founded 2015

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 91
Average round size
info
The average size of a deal this fund participated in
$10M
Portfolio companies 55
Rounds per year 15.17
Lead investments 28
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.42
Exits 4
Key employees 4
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Life Science
  • Artificial Intelligence
Summary

Oxford Sciences Innovation is the famous Corporate Investor, which was founded in 2015. The company was established in Europe in United Kingdom. The main department of described Corporate Investor is located in the Oxford.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Oxford Sciences Innovation, startups are often financed by Oxford University Innovation, IP Group Plc, Innovate UK. The meaningful sponsors for the fund in investment in the same round are IP Group Plc, Woodford Investment Management, Rt Capital Management. In the next rounds fund is usually obtained by Parkwalk Advisors, Oxford University Innovation, Innovate UK.

The fund has no exact preference in some founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline YASA Motors, Genomics, Proxisense For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom. Among the most popular fund investment industries, there are Life Science, Health Care.

When the investment is from Oxford Sciences Innovation the average startup value is 50-100 millions dollars. The fund is constantly included in 7-12 deals per year. The high activity for fund was in 2018. Deals in the range of 5 - 10 millions dollars are the general things for fund. Speaking about the real fund results, this Corporate Investor is 40 percentage points more often commits exit comparing to other organizations.

Read more

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Ultromics

Artificial Intelligence
Computer Vision
Health Care
Health Diagnostics
Medical
Software
$32M16 Aug 2021 Oxford, England, United Kingdom

Pepgen

Biotechnology
Clinical Trials
Medical
$112M05 Aug 2021 Oxford, England, United Kingdom

Rey

Health Care
$10M27 Jul 2021 Austin, Texas, United States

Orbit Discovery

Biotechnology
Health Care
Manufacturing
$7M20 Jul 2021 Oxford, England, United Kingdom

Oxford Endovascular

Health Care
Medical
$9M08 Apr 2021 Oxford, England, United Kingdom

Caristo Diagnostics

Biopharma
Biotechnology
Health Care
Health Diagnostics
Medical
Medical Device
30 Mar 2021 Oxford, England, United Kingdom

Genomics

Biopharma
Biotechnology
Genetics
Health Care
Life Science
Medical
Therapeutics
$30M01 Mar 2021 Oxford, England, United Kingdom

Evox Therapeutics

Biotechnology
Health Care
Pharmaceutical
$94M18 Feb 2021 Oxford, England, United Kingdom

Biotechnology
Life Science
Medical
$32M10 Feb 2021 Oxford, England, United Kingdom
News
Ultromics Raises $33M in Series B Funding

– Ultromics, an Oxford, UK-based company focused on advancing AI enabled cardiovascular imaging solutions, raised $33M in series B funding.
– The round was led by Blue Venture Fund with participation from Optum Ventures, GV and Oxford Sciences Innovation.
– The new investment will be aimed at accelerating the use of AI-enabled echocardiograms to improve patient care, and bring improved diagnostic quality and resource savings to hospitals.

Rey Raises $10M in Series A Funding

– Rey, an Austin TX-based mental health and wellness company, raised $10m in Series A funding.
– The round was led by Optum Ventures with participation from Oxford Sciences Innovation.
– The company intends to expand its consumer reach with the new funding.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Oxford Sciences Innovation?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: